Key result
Overexpression of HSP75 prevented cardiac hypertrophy and fibrosis induced by pressure overload in mice by inhibiting TAK/P38, JNK, and AKT signaling pathways.
Why the study?
Does overexpression of HSP75 prevent cardiac hypertrophy and fibrosis in a mouse model of pressure overload?
Does overexpression of HSP75 prevent cardiac hypertrophy and fibrosis in a mouse model of pressure overload?
HSP75 overexpression protects against pressure overload-induced cardiac hypertrophy and fibrosis in mice, suggesting a potential therapeutic target for heart failure.
Answers are grounded in this paper and cite their sources.
Should not change clinical practice; leaves open HSP75 as a therapeutic target in cardiac hypertrophy.
Cardiac hypertrophy, a major determinant of heart failure, is associated with heat shock proteins (HSPs). HSP75 has been reported to protect against environmental stresses; however, its roles in cardiac hypertrophy remain unclear. Here, we generated cardiac-specific inducible HSP75 transgenic mice (TG) and cardiac hypertrophy was developed at 4 weeks after aortic banding in TG mice and wild-type littermates. The results revealed that overexpression of HSP75 prevented cardiac hypertrophy and fibrosis as assessed by heart weight/body weight ratio, heart weight/tibia length ratio, echocardiographic and hemodynamic parameters, cardiomyocyte width, left ventricular collagen volume, and gene expression of hypertrophic markers. Further studies showed that overexpression of HSP75 inhibited the activation of TAK/P38, JNK, and AKT signaling pathways. Thus, HSP75 likely reduces the hypertrophy and fibrosis induced by pressure overload through blocking TAK/P38, JNK, and AKT signaling pathways.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2011) studied Cardiac hypertrophy and fibrosis. Overexpression of HSP75 vs. Wild-type littermates was evaluated on Cardiac hypertrophy and fibrosis. Overexpression of HSP75 prevented cardiac hypertrophy and fibrosis induced by pressure overload in mice by inhibiting TAK/P38, JNK, and AKT signaling pathways.
Synapse has enriched 10 related papers. Consider them for comparative context: